Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Stables

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Chemical & Pharmaceutical Bulletin|June 1, 2001
Amino acid derivatives with anticonvulsant activityR Paruszewski, M Strupińska, J P Stables, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1997
Anticonvulsant and neurotoxicological properties of 4-amino-N-(2-ethylphenyl)benzamide, a potent ameltolide analogueO Diouf, M Bourhim, D M Lambert, et al.
Journal De Pharmacie De Belgique|February 12, 1998
[Rational conception, synthesis and evaluation of phenytoinergic potential anticonvulsants. A series ofretrobenzamides: N-(nitrophenyl) benzamides and N-(aminophenyl) benzamides]M Bourhim, M D Kanyonyo, D M Lambert, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|November 16, 2006
Quantum mechanical modeling of N4-(2, 5-disubstituted phenyl) semicarbazones: synthesis and anticonvulsant activity of N4-(2, 5-dimethylphenyl/ -2-fluoro-5-methyl phenyl) semicarbazonesM Shalini, P Yogeeswari, D Sriram, et al.
Farmaco (Societa Chimica Italiana : 1989)|January 18, 2005
Anticonvulsant and neurotoxicity evaluation of some 6-substituted benzothiazolyl-2-thiosemicarbazonesP Yogeeswari, D Sriram, S Mehta, et al.
Life Sciences|November 7, 1998
Anticonvulsant phenytoinergic pharmacophores and anti-HIV activity--preliminary evidence for the dual requirement of the 4-aminophthalimide platform and the N-(1-adamantyl) substitution for antiviral propertiesJ Vamecq, K Van derpoorten, J H Poupaert, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 6, 1998
Magnesium deficiency-dependent audiogenic seizures (MDDASs) in adult mice: a nutritional model for discriminatory screening of anticonvulsant drugs and original assessment of neuroprotection propertiesP Bac, P Maurois, C Dupont, et al.
Epilepsia|June 1, 1995
Comparative anticonvulsant activity and neurotoxicity of 4-amino-N-(2,6-dimethylphenyl)phthalimide and prototype antiepileptic drugs in mice and ratsV Bailleux, L Vallée, J P Nuyts, et al.
Die Pharmazie|February 1, 1996
Structural modifications of the primary amino group of anticonvulsant aryl semicarbazonesJ R Dimmock, R N Puthucode, M S Lo, et al.
Epilepsy Research|November 1, 1995
Progress report on new antiepileptic drugs. A summary of the Second Eilat ConferenceJ P Stables, M Bialer, S I Johannessen, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Chemical & Pharmaceutical Bulletin|June 1, 2001
Amino acid derivatives with anticonvulsant activityR Paruszewski, M Strupińska, J P Stables, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1997
Anticonvulsant and neurotoxicological properties of 4-amino-N-(2-ethylphenyl)benzamide, a potent ameltolide analogueO Diouf, M Bourhim, D M Lambert, et al.
Journal De Pharmacie De Belgique|February 12, 1998
[Rational conception, synthesis and evaluation of phenytoinergic potential anticonvulsants. A series ofretrobenzamides: N-(nitrophenyl) benzamides and N-(aminophenyl) benzamides]M Bourhim, M D Kanyonyo, D M Lambert, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|November 16, 2006
Quantum mechanical modeling of N4-(2, 5-disubstituted phenyl) semicarbazones: synthesis and anticonvulsant activity of N4-(2, 5-dimethylphenyl/ -2-fluoro-5-methyl phenyl) semicarbazonesM Shalini, P Yogeeswari, D Sriram, et al.
Farmaco (Societa Chimica Italiana : 1989)|January 18, 2005
Anticonvulsant and neurotoxicity evaluation of some 6-substituted benzothiazolyl-2-thiosemicarbazonesP Yogeeswari, D Sriram, S Mehta, et al.
Life Sciences|November 7, 1998
Anticonvulsant phenytoinergic pharmacophores and anti-HIV activity--preliminary evidence for the dual requirement of the 4-aminophthalimide platform and the N-(1-adamantyl) substitution for antiviral propertiesJ Vamecq, K Van derpoorten, J H Poupaert, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 6, 1998
Magnesium deficiency-dependent audiogenic seizures (MDDASs) in adult mice: a nutritional model for discriminatory screening of anticonvulsant drugs and original assessment of neuroprotection propertiesP Bac, P Maurois, C Dupont, et al.
Epilepsia|June 1, 1995
Comparative anticonvulsant activity and neurotoxicity of 4-amino-N-(2,6-dimethylphenyl)phthalimide and prototype antiepileptic drugs in mice and ratsV Bailleux, L Vallée, J P Nuyts, et al.
Die Pharmazie|February 1, 1996
Structural modifications of the primary amino group of anticonvulsant aryl semicarbazonesJ R Dimmock, R N Puthucode, M S Lo, et al.
Epilepsy Research|November 1, 1995
Progress report on new antiepileptic drugs. A summary of the Second Eilat ConferenceJ P Stables, M Bialer, S I Johannessen, et al.
Pageof 6